ArticleNeuropsychopharmacology reports2020

Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic-like effects without affecting cognitive enhancement and cataleptic effects in rats.

Keita Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.